Fangzhou (HKSE:06086) Days Payable : 55.52 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Fangzhou Days Payable?

Fangzhou's average Accounts Payable for the six months ended in Dec. 2024 was HK$368 Mil. Fangzhou's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$1,211 Mil. Hence, Fangzhou's Days Payable for the six months ended in Dec. 2024 was 55.52.

The historical rank and industry rank for Fangzhou's Days Payable or its related term are showing as below:

HKSE:06086' s Days Payable Range Over the Past 10 Years
Min: 43.04 Med: 46.97 Max: 54.75
Current: 54.75

During the past 4 years, Fangzhou's highest Days Payable was 54.75. The lowest was 43.04. And the median was 46.97.

HKSE:06086's Days Payable is ranked worse than
53.4% of 603 companies
in the Healthcare Providers & Services industry
Industry Median: 58.42 vs HKSE:06086: 54.75

Fangzhou's Days Payable declined from Dec. 2023 (59.21) to Dec. 2024 (55.52). It may suggest that Fangzhou accelerated paying its suppliers.

Fangzhou Days Payable Historical Data

The historical data trend for Fangzhou's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fangzhou Days Payable Chart

Fangzhou Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Days Payable

45.42

43.04

48.52

54.03

Fangzhou Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial			-	39.28	59.21	54.91	55.52

Competitive Comparison of Fangzhou's Days Payable

For the Pharmaceutical Retailers subindustry, Fangzhou's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fangzhou's Days Payable Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fangzhou's Days Payable distribution charts can be found below:

* The bar in red indicates where Fangzhou's Days Payable falls into.

Save Embed

;

Save Embed

;

Fangzhou Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Fangzhou's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (320.416	+	372.219)	/	2 )	/	2339.725	*	365
=	346.3175					/	2339.725	*	365
=	54.03

Fangzhou's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (364.486	+	372.219)	/	2 )	/	1210.905	*	365 / 2
=	368.3525					/	1210.905	*	365 / 2
=	55.52

Fangzhou Days Payable Related Terms

Thank you for viewing the detailed overview of Fangzhou's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Fangzhou Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fangzhou Inc (HKSE:06086) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

4th Street, Floor 1-2, Building S, Kehui Jingu, No. 99, Science Avenue, Luogang Science City, Huangpu District, Guangdong Province, Guangzhou, CHN

Website

https://investors.jianke.com

Fangzhou Inc is a online chronic disease management platform in China. It has focus on chronic disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. The company provide comprehensive medical services and online retail pharmacy services through Jianke Platform. The principal segment of the group are online retail pharmacy services, comprehensive medical services and customized content and marketing solutions. Key revenue is generated from Online retail pharmacy services.

Executives

Asia Tech Holdings Limited	2201 Interest of corporation controlled by you
Vistra Trust (hong Kong) Limited	2301 Trustee
Crescent China Investment Management Ltd.	2102 Investment manager
Hand David Mckee	2201 Interest of corporation controlled by you
Rojanavanichkul Danai	2201 Interest of corporation controlled by you
Veneto Holdings Ltd.	2201 Interest of corporation controlled by you
Tech-med Cayman Iii Ltd.	2201 Interest of corporation controlled by you
Tech-med Investments (s) Pte. Ltd.	2101 Beneficial owner
Cp Pharmatech Singapore Pte. Ltd.	2101 Beneficial owner
Asia Tech Investments Ltd.	2101 Beneficial owner
Crescent Acso Investment Management Ltd	2201 Interest of corporation controlled by you
Crescent Trident Singapore Pte. Ltd.	2101 Beneficial owner
Xie Fangmin	2201 Interest of corporation controlled by you
Zhou Feng	2201 Interest of corporation controlled by you
Fangrong Management Limited	2101 Beneficial owner

Fangzhou Headlines

No Headlines